Pembrolizumab-induced autoimmune haemolytic anemia in a patient with chronic lymphocytic leukaemia successfully treated with ibrutinib.
Saved in:
| Title: | Pembrolizumab-induced autoimmune haemolytic anemia in a patient with chronic lymphocytic leukaemia successfully treated with ibrutinib. |
|---|---|
| Authors: | Yun NK; Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA nicole_k_yun@rush.edu., Alrifai T; Division of Hematology, Oncology, and Stem Cell Transplant, Rush University Medical Center, Chicago, Illinois, USA., Miller IJ; Department of Pathology, Rush University Medical Center, Chicago, Illinois, USA., Larson ML; Division of Hematology, Oncology, and Stem Cell Transplant, Rush University Medical Center, Chicago, Illinois, USA. |
| Source: | BMJ case reports [BMJ Case Rep] 2021 Sep 21; Vol. 14 (9). Date of Electronic Publication: 2021 Sep 21. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
